Given that LM is a risk factor for LAS and the lack of effective treatment for the deadly LAS, potential new prophylactic strategies based on our findings to targeting autophagy and/or its downstream OPN expression will have important clinical implications for LM patients. This evidence concerns the gene SPP1 and lymphangioma.